China Pioneer Pharma Holdings Limited (1345.HK)

HKD 2.23

(0.0%)

Total Liabilities Summary of China Pioneer Pharma Holdings Limited

China Pioneer Pharma Holdings Limited's latest annual total liabilities in 2023 was 513.13 Million CNY , down -6.56% from previous year.
China Pioneer Pharma Holdings Limited's latest quarterly total liabilities in 2023 FY was 513.13 Million CNY , down -6.56% from previous quarter.
China Pioneer Pharma Holdings Limited reported annual total liabilities of 549.17 Million CNY in 2022, up 31.54% from previous year.
China Pioneer Pharma Holdings Limited reported annual total liabilities of 417.49 Million CNY in 2021, down -19.2% from previous year.
China Pioneer Pharma Holdings Limited reported quarterly total liabilities of 513.13 Million CNY for 2023 Q4, down 0.0% from previous quarter.
China Pioneer Pharma Holdings Limited reported quarterly total liabilities of 513.13 Million CNY for 2023 FY, down -6.56% from previous quarter.

Annual Total Liabilities Chart of China Pioneer Pharma Holdings Limited (2023 - 2012)

Historical Annual Total Liabilities of China Pioneer Pharma Holdings Limited (2023 - 2012)

Year	Total Liabilities	Total Liabilities Growth
2023	513.13 Million CNY	-6.56%
2022	549.17 Million CNY	31.54%
2021	417.49 Million CNY	-19.2%
2020	516.72 Million CNY	27.09%
2019	406.59 Million CNY	22.49%
2018	331.95 Million CNY	-52.1%
2017	692.98 Million CNY	8.63%
2016	637.92 Million CNY	-22.73%
2015	825.58 Million CNY	-37.87%
2014	1.32 Billion CNY	58.27%
2013	839.63 Million CNY	17.31%
2012	715.72 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 Q2	441.55 Million CNY	0.0%
2023 Q4	513.13 Million CNY	0.0%
2023 FY	513.13 Million CNY	-6.56%
2022 Q2	359.78 Million CNY	0.0%
2022 FY	549.17 Million CNY	31.54%
2022 Q4	549.17 Million CNY	0.0%
2021 Q2	247.61 Million CNY	0.0%
2021 Q4	417.49 Million CNY	0.0%
2021 FY	417.49 Million CNY	-19.2%
2020 FY	516.72 Million CNY	27.09%
2020 Q2	289.25 Million CNY	0.0%
2020 Q4	516.72 Million CNY	0.0%
2019 Q4	406.59 Million CNY	0.0%
2019 Q2	276.48 Million CNY	0.0%
2019 FY	406.59 Million CNY	22.49%
2018 FY	331.95 Million CNY	-52.1%
2018 Q4	331.95 Million CNY	0.0%
2018 Q2	404.7 Million CNY	0.0%
2017 Q4	692.98 Million CNY	0.0%
2017 FY	692.98 Million CNY	8.63%
2017 Q2	642.56 Million CNY	0.0%
2016 Q4	637.92 Million CNY	0.0%
2016 FY	637.92 Million CNY	-22.73%
2016 Q2	711.29 Million CNY	0.0%
2015 Q2	1.42 Billion CNY	0.0%
2015 FY	825.58 Million CNY	-37.87%
2015 Q4	825.58 Million CNY	0.0%
2014 Q2	935.04 Million CNY	0.0%
2014 Q4	1.32 Billion CNY	0.0%
2014 FY	1.32 Billion CNY	58.27%
2013 FY	839.63 Million CNY	17.31%
2013 Q4	839.63 Million CNY	0.0%
2013 Q2	1.04 Billion CNY	0.0%
2012 Q4	715.72 Million CNY	0.0%
2012 FY	715.72 Million CNY	0.0%

Peer Total Liabilities Comparison of China Pioneer Pharma Holdings Limited

Name	Total Liabilities	Total Liabilities Difference
China Healthwise Holdings Limited	145.27 Million HKD	-253.226%
Tycoon Group Holdings Limited	445.4 Million HKD	-15.207%
Beijing Tong Ren Tang Chinese Medicine Company Limited	413.75 Million HKD	-24.02%